Multiple sclerosis causes significant physical disability in more than 30% of patients with the disease. Traditionally, the nerve damage was considered irreversible, with limited benefits experienced from traditional approaches such as steroids and other medications. There may be an alternative method for managing the symptoms of this disorder. Please fill out a medical review form, or call our office in Glenview, Illinois to learn more about it.
Multiple sclerosis is an inflammatory neurodegenerative disease in which your immune system attacks the myelin sheath on nerves in the brain and spinal cord.
The myelin sheath is a covering that protects the axon (the long projection that extends from the body of the nerve cell). It also enhances the transmission of electrical impulses.
Over time, multiple sclerosis causes nerve deterioration and permanent damage. Patients experience either nerve pain (neuropathic pain) and/or musculoskeletal (nociceptive) pain caused by damage to the ligaments, muscles, tendons, and soft tissue.
The symptoms that develop depend on which nerves are affected and the amount of damage. A few examples of possible symptoms include:
The four types of multiple sclerosis are:
If you have been diagnosed with multiple sclerosis, researchers suggest seeking treatment as soon as possible. Researchers have found that multiple sclerosis creates more damage in the first year than in later years.
Multiple sclerosis is traditionally treated using either disease-modifying medications, self-injected medications, oral, infused medications and corticosteroids (steroids). Other treatments include physical therapy, speech therapy, and mobility aids. These medications carry several possible side effects.
Disease-modifying medications for MS: address the inflammatory issues inherent in MS and by changing the way the immune system responds. Preventing relapses is a proven effect of the currently available disease-modifying therapies, but improving symptoms is not. Side effects may include: infection, decreased level of white blood cells, heart failure, liver damage, kidney failure, and increased risk of certain cancers.
Self-injecting and oral medications for MS: side effects may include low red and white blood cell counts or platelets, thyroid problems, seizures, liver problems, heart failure, progressive multifocal leukoencephalopathy (PML)
Infused medications for MS: side effects may include an increased risk to AML (acute myelogenous leukemia and colon cancer, and kidney disease.
Corticosteroids for MS: long-term use can cause several side effects such as high blood pressure, osteoporosis, glaucoma, and increased chance of infection. There is no evidence that long-term use of corticosteroids helps reduce symptoms or slows progression of MS, according to the NMSS.
Cost of Healthcare: The Journal of Medical Economics published a study that discovered that the total cost of healthcare for MS ranged from approx. $8,500 to over $50,000 per year during the period studied (1999 to 2008), Prescription drugs were the cause for a large percentage of those costs.
Multiple sclerosis is a progressive disease that gets worse over time. It causes extensive nerve damage. There is no medication that can reverse the damage on the market today. Stem cell therapy offers hope in reversing, stopping, or slowing down the progression of such a debilitating disease.
GIOSTAR (Global Institute of Stem Cell Therapy and Research) is home to the top experts in the field of stem cell research, and provides scientific know-how to GIOSTAR-CHICAGO. GIOSTAR-CHICAGO is an independently run facility from GIOSTAR. Involved in the field of stem cell research for almost two decades in the U.S.A, GIOSTAR has provided treatments to thousands of patients using their advanced protocols outside of the United States. GIOSTAR believes in the potential of supplementing traditional treatments for multiple sclerosis (such as medication) with cellular rejuvenation therapy. Focusing solely on one particular form of treatment does not necessarily yield the desired results.
GIOSTAR opened the world’s first stem cell therapy hospital in India, and has plans to continue building stem cell treatment centers with health care partners around the world. Their goal is to develop treatments for several diseases, and offer hope to millions suffering around the globe with safe, effective and affordable healthcare.
Within the body, there are different sources of stem cells - known as the "mother" or "master" cells capable of differentiating into virtually any type of cell. It has been documented by several scientific publications that stem cells may differentiate into a specific cell or tissue type. This suggests the possibility to develop the treatment for multiple sclerosis.